ESMO 2023 Conference Review focus on Haematology

In this edition:

ICT01 in relapsed/refractory haematological cancer
SAR443579 in AML, B-ALL & MDS
Survival outcomes in primary ocular adnexal MALT lymphoma
Anti-PD-1 therapy in peripheral T cell lymphoma
Radiotherapy + toripalimab in extranodal NK/T cell lymphoma
A mobile app for haematopoietic stem cell transplant patients
A CAR T-cell educational nursing programme
Ukraine-EU transfers of cancer patients
Spending on orphan cancer drugs
 

Please login below to download this issue (PDF)

Subscribe